(Q46707928)

24 December 2017

title

Evidence for adjuvanticity of anthrax edema toxin (English)

1 reference

24 December 2017

author name string

Anne Quesnel-Hellmann

1

1 reference

24 December 2017

Aurélie Cleret

2

1 reference

24 December 2017

Dominique R Vidal

3

1 reference

24 December 2017

Jean-Nicolas Tournier

4

1 reference

24 December 2017

language of work or name

English

0 references

publication date

30 August 2005

1 reference

24 December 2017

published in

Vaccine

1 reference

24 December 2017

volume

24

1 reference

24 December 2017

issue

6

1 reference

24 December 2017

page(s)

699-702

1 reference

24 December 2017

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.065

1 reference

Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.065

Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.065

Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.065

Anthrax edema toxin cooperates with lethal toxin to impair cytokine secretion during infection of dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.065

Rabbit and nonhuman primate models of toxin-targeting human anthrax vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.065

Characterisation of adsorbed anthrax vaccine by two-dimensional gel electrophoresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.065

The potential of oligodeoxynucleotides as mucosal and parenteral adjuvants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.065

Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor beta1 and beta2 chain expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.065

Cholera Toxin Promotes the Induction of Regulatory T Cells Specific for Bystander Antigens by Modulating Dendritic Cell Activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.065

Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.065

Modulation of innate and acquired immune responses by Escherichia coli heat-labile toxin: distinct pro- and anti-inflammatory effects of the nontoxic AB complex and the enzyme activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.065

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.065

Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.065

Crystal structure of a complex between anthrax toxin and its host cell receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.065

10.1016/J.VACCINE.2005.08.065

7 January 2021

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017